These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27899995)

  • 1. Systematic tracking of disrupted modules identifies significant genes and pathways in hepatocellular carcinoma.
    Zhang MH; Shen QH; Qin ZM; Wang QL; Chen X
    Oncol Lett; 2016 Nov; 12(5):3285-3295. PubMed ID: 27899995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic tracking of dysregulated modules identifies disrupted pathways in narcolepsy.
    Liu Z; Zhao J; Tan Y; Tang M; Li G
    Int J Clin Exp Med; 2015; 8(6):9384-93. PubMed ID: 26309600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of disrupted pathways in ulcerative colitis-related colorectal carcinoma by systematic tracking the dysregulated modules.
    Wu D; Li Q; Song G; Lu J
    J BUON; 2016; 21(2):366-74. PubMed ID: 27273946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulated module approach identifies disrupted genes and pathways associated with acute myelocytic leukemia.
    Fang Y; Xie LN; Liu XM; Yu Z; Kong FS; Song NX; Zhou F
    Eur Rev Med Pharmacol Sci; 2015 Dec; 19(24):4811-26. PubMed ID: 26744873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal Identification of Dysregulated Genes and Pathways in Clear Cell Renal Cell Carcinoma Based on Systematic Tracking of Disrupted Modules.
    Wang SM; Sun ZQ; Li HY; Wang J; Liu QY
    Comput Math Methods Med; 2015; 2015():313740. PubMed ID: 26543493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic Tracking of Disrupted Modules Identifies Altered Pathways Associated with Congenital Heart Defects in Down Syndrome.
    Chen D; Zhang Z; Meng Y
    Med Sci Monit; 2015 Nov; 21():3334-42. PubMed ID: 26524729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic tracking of altered modules identifies disrupted pathways in teratozoospermia.
    Huang ZQ; Wang GX; Jiang XL; Tian EP; Yao WL; Zeng T
    Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic module approach identifies altered genes and pathways in four types of ovarian cancer.
    Liu J; Wang HL; Ma FM; Guo HP; Fang NN; Wang SS; Li XH
    Mol Med Rep; 2017 Dec; 16(6):7907-7914. PubMed ID: 28983627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of key biomarkers involved in osteosarcoma using altered modules.
    Liu ZZ; Cui ST; Tang B; Wang ZZ; Luan ZX
    Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying disrupted pathways by tracking altered modules in type 2 DM-related heart failure.
    Liu H; Han X; Li Y
    Herz; 2017 Feb; 42(1):98-106. PubMed ID: 27363418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic tracking of altered modules identifies the key biomarkers involved in chronic lymphocytic leukemia.
    Lu X; Wu Z; Zhao XY; Li CF; Kan SF
    Oncol Lett; 2019 Feb; 17(2):2351-2355. PubMed ID: 30675301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of hub genes and pathways associated with hepatocellular carcinoma based on network strategy.
    Liu J; Hua P; Hui L; Zhang LL; Hu Z; Zhu YW
    Exp Ther Med; 2016 Oct; 12(4):2109-2119. PubMed ID: 27703495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
    Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
    Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
    Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
    Gene; 2019 May; 698():9-18. PubMed ID: 30825595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction and analysis of weighted genes in hepatocellular carcinoma using bioinformatics analysis.
    Zhang Q; Sun S; Zhu C; Zheng Y; Cai Q; Liang X; Xie H; Zhou J
    Mol Med Rep; 2019 Apr; 19(4):2479-2488. PubMed ID: 30720105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-124-3p expression and its prospective functional pathways in hepatocellular carcinoma: A quantitative polymerase chain reaction, gene expression omnibus and bioinformatics study.
    He RQ; Yang X; Liang L; Chen G; Ma J
    Oncol Lett; 2018 Apr; 15(4):5517-5532. PubMed ID: 29552191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical genes of hepatocellular carcinoma revealed by network and module analysis of RNA-seq data.
    Yang MR; Zhang Y; Wu XX; Chen W
    Eur Rev Med Pharmacol Sci; 2016 Oct; 20(20):4248-4256. PubMed ID: 27831650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardioprotection Effects of Sevoflurane by Regulating the Pathway of Neuroactive Ligand-Receptor Interaction in Patients Undergoing Coronary Artery Bypass Graft Surgery.
    Wang J; Cheng J; Zhang C; Li X
    Comput Math Methods Med; 2017; 2017():3618213. PubMed ID: 28348638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silymarin-mediated regulation of the cell cycle and DNA damage response exerts antitumor activity in human hepatocellular carcinoma.
    Cui H; Li TL; Guo HF; Wang JL; Xue P; Zhang Y; Fan JH; Li ZP; Gao YJ
    Oncol Lett; 2018 Jan; 15(1):885-892. PubMed ID: 29399153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Hepatocellular Carcinoma-Related Potential Genes and Pathways Through Bioinformatic-Based Analyses.
    Wan Z; Zhang X; Luo Y; Zhao B
    Genet Test Mol Biomarkers; 2019 Nov; 23(11):766-777. PubMed ID: 31633428
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.